Charl Zyl is the founder of Lundbeck. Charl van Zyl is the CEO of Lundbeck, a Danish drugmaker. Based in Valby, Denmark.
Charl van Zyl is the CEO of Lundbeck, a Danish drugmaker. The company develops treatments for neurological and psychiatric disorders, including the migraine treatment Vyepti and the schizophrenia drug Abilify Maintena. Under his leadership, Lundbeck has reported strong financial results, with significant growth in revenue and EBITDA. The company focuses on a "Focused Innovator Strategy" encompassing growth, innovation, and funding, and has been transforming its operations, including transitioning to a commercial partnership model in 27 markets.
Full founder directory · Investor directory · Company funding database · Fundraising library